UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial

Nature medicine, 2021-10, Vol.27 (10), p.1789-1796

2021

Volltextzugriff (PDF)

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Journal for immunotherapy of cancer, 2016-10, Vol.4 (1), p.60-60, Article 60

2016

Volltextzugriff (PDF)

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

Journal of the American Academy of Dermatology, 2012-12, Vol.67 (6), p.1375-1379

2012

Volltextzugriff (PDF)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of oncology, 2015-11, Vol.26 (11), p.2267-2274

2015

Volltextzugriff (PDF)

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

Annals of oncology, 2011-04, Vol.22 (4), p.787-793

2011

Volltextzugriff (PDF)

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Annals of oncology, 2015-07, Vol.26 (7), p.1481-1487

2015

Volltextzugriff (PDF)

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii736-viii736

2018

Volltextzugriff (PDF)

Pathological complete response after neoadjuvant pembrolizumab and radiation

Clinical and experimental dermatology, 2019-07, Vol.44 (5), p.570-573

2019

Volltextzugriff (PDF)

Spectroscopic and electrochemical properties of di-2-thienyl ketone thiosemicarbazone (dtktsc): electrochemical reactions with electrophiles (H+ and CO2)

Electrochimica acta, 2016-09, Vol.212, p.1010-1020

2016

Volltextzugriff (PDF)

Characterization of a messenger RNA polynucleotide vaccine vector

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (7), p.1397-1400

1995

Volltextzugriff (PDF)

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Clinical cancer research, 2000-01, Vol.6 (1), p.34-41

2000

Volltextzugriff (PDF)

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

The New England journal of medicine, 2011-06, Vol.364 (26), p.2507-2516

2011

Volltextzugriff (PDF)

LBA39 Final 5-year results of the phase II, multicenter, randomized, open-label trial of talimogene laherparepvec (T-VEC) neoadjuvant treatment (Tx) plus surgery vs immediate surgery in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL)

Annals of oncology, 2022-09, Vol.33, p.S1406

2022

Volltextzugriff (PDF)

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Clinical cancer research, 1999-09, Vol.5 (9), p.2330-2337

1999

Volltextzugriff (PDF)

Single-step synthesis of D3h-symmetric bicyclooxacalixarenes

Organic letters, 2005-08, Vol.7 (16), p.3505-3507

2005

Volltextzugriff (PDF)

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Vaccine, 2004-01, Vol.22 (5-6), p.773-780

2004

Volltextzugriff (PDF)

Selected strategies to augment polynucleotide immunization

Gene therapy, 1996-01, Vol.3 (1), p.67

1996

Volltextzugriff (PDF)

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

Nature medicine, 2021-10, Vol.27 (10), p.1789-1796

2021

Volltextzugriff (PDF)

Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma

Human gene therapy, 2005, Vol.16 (1), p.91-100

2005

Volltextzugriff (PDF)

Immune response to a carcinoembryonic antigen polynucleotide vaccine

Cancer research (Chicago, Ill.), 1994-03, Vol.54 (5), p.1164-1168

1994

Volltextzugriff (PDF)

Treatment of Advanced Melanoma With Concurrent Radiation and Programmed Cell Death 1 Inhibitors

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E754-E755

2017

Volltextzugriff (PDF)

LBA66Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

LBA66 - Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

Annals of oncology, 2019-10, Vol.30, p.v903-v903

2019

Volltextzugriff (PDF)

Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

Annals of oncology, 2019-10, Vol.30, p.v903

2019

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(203)

Publikationsform

Sprache

Englisch
(269)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
Annals Of Oncology
(10)
Journal Of Immunotherapy
(9)
Neurology
(9)
Clinical Cancer Research
(8)
American Journal Of Pharmaceutical Education
(6)
Epilepsia
(6)
Gene Therapy
(6)
Age And Ageing
(5)
Cancer Research
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Pathological complete response after neoadjuvant pembrolizumab and radiation

Spectroscopic and electrochemical properties of di-2-thienyl ketone thiosemicarbazone (dtktsc): electrochemical reactions with electrophiles (H+ and CO2)

Characterization of a messenger RNA polynucleotide vaccine vector

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

LBA39 Final 5-year results of the phase II, multicenter, randomized, open-label trial of talimogene laherparepvec (T-VEC) neoadjuvant treatment (Tx) plus surgery vs immediate surgery in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL)

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Single-step synthesis of D3h-symmetric bicyclooxacalixarenes

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Selected strategies to augment polynucleotide immunization

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma

Immune response to a carcinoembryonic antigen polynucleotide vaccine

Treatment of Advanced Melanoma With Concurrent Radiation and Programmed Cell Death 1 Inhibitors

LBA66Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

LBA66 - Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

Primary 2-year (yr) results of a phase II, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma

Aktive Filter

Suchergebnisse filtern